Trials / Completed
CompletedNCT02992314
Determination of the Safety and Effectiveness of an Oral Rinse in the Reduction of Medication Associated Metallic Taste
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- You First Services · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Patients taking chemotherapeutic agents often do not comply well with their dosing regiment since many of these medications cause a metallic taste in the mouth. The primary intent is to determine the effectiveness of the oral rinse in reducing the metallic taste in the mouth associated with various chemotherapeutic agents. This clinical study a randomized, double-blind, single-treatment, parallel design with a placebo as the control. The duration of the trial will be 1 month.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Metaqil™ Oral Rinse | Metaqil™ is a proprietary formulation of GRAS ingradients |
| DEVICE | Placebo | Placebo formulation with out the active ingredients |
Timeline
- Start date
- 2017-05-22
- Primary completion
- 2018-09-18
- Completion
- 2018-12-31
- First posted
- 2016-12-14
- Last updated
- 2021-01-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02992314. Inclusion in this directory is not an endorsement.